0.00
Cargo Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.47
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$216.19M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
0.00
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CRGX
Cargo Therapeutics Inc
|
0.00 | 216.19M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Why retail investors pile into CARGO Therapeutics Inc. stockTrade Entry Report & Expert Curated Trade Setup Alerts - Newser
Setup Watch: Will CARGO Therapeutics Inc. stock benefit from green energy trendsJuly 2025 Highlights & Weekly Breakout Stock Alerts - moha.gov.vn
Published on: 2025-11-28 15:12:51 - BỘ NỘI VỤ
Cargo Therapeutics stock tumbles after trial setback - MSN
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround - MSN
Cargo Therapeutics stock rating cut by Jefferies to Hold - MSN
Can CARGO Therapeutics Inc. stock sustain revenue growth2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Analyzing CARGO Therapeutics Inc. with multi timeframe chartsTrade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
How CARGO Therapeutics Inc. stock compares to growth peers2025 Risk Factors & Growth Focused Investment Plans - newser.com
CARGO Therapeutics Inc. stock outlook for YEARWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Can CARGO Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Signal strength of CARGO Therapeutics Inc. stock in tech scannersEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
How CARGO Therapeutics Inc. stock performs in weak economyIPO Watch & Daily Profit Maximizing Tips - newser.com
Will CARGO Therapeutics Inc. price bounce be sustainable2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
Using data tools to time your CARGO Therapeutics Inc. exit2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
How CARGO Therapeutics Inc. stock benefits from global expansionJuly 2025 Retail & Verified Momentum Watchlists - newser.com
Using Bollinger Bands to evaluate CARGO Therapeutics Inc.Insider Buying & Stock Portfolio Risk Control - newser.com
Applying chart zones and confluence areas to CARGO Therapeutics Inc.Bond Market & Community Verified Watchlist Alerts - newser.com
Is CARGO Therapeutics Inc. stock a buy in volatile markets2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Measuring CARGO Therapeutics Inc.’s beta against major indicesTreasury Yields & High Accuracy Investment Entry Signals - newser.com
Is CARGO Therapeutics Inc. stock a top momentum playEarnings Growth Summary & Step-by-Step Swing Trade Plans - Fundação Cultural do Pará
Loss Report: Is CARGO Therapeutics Inc. stock ready for breakout - Fundação Cultural do Pará
Is CARGO Therapeutics Inc. stock a buy before product launchesPortfolio Return Report & Technical Confirmation Trade Alerts - newser.com
Detecting price anomalies in CARGO Therapeutics Inc. with AIWeekly Investment Summary & Accurate Trade Setup Notifications - newser.com
Piper Sandler cuts Cargo Therapeutics rating to neutral - MSN
Relative strength of CARGO Therapeutics Inc. in sector analysisWeekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):